Pathophysiological basis of cerebral vasospasm following aneurysmal subarachnoid haemorrhage

Journal of Clinical Neuroscience

Volumn 4, Issue 2, 1997, Pages 122-131

  Khurana, Vini G ^a,b   Besser, Michael ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b NONE   (Australia)

Author keywords

Aneurysm; Carbon monoxide; Cerebral vasospasm; Haemoglobin; Nitric oxide; Stroke; Subarachnoid haemorrhage

Indexed keywords

EID: 0008193811     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0967-5868(97)90061-8     Document Type: Review

References (101)

1. Foley PL, Takenaka K, Kassell NF, Lee KS. Cytotoxic effects of bloody cerebrospinal fluid on cerebral endothelial cells in culture. J Neurosurg 1994; 81: 87-92.
2. Sundt TM Jr, Kobayashi S, Fode NC, Whisnant JP. Results and complications of surgical management of 809 intracranial aneurysms in 722 cases: related and unrelated to grade of patient, type of aneurysm, and timing of surgery. J Neurosurg 1982; 56: 753-765.
3. Dorsch NWC, King MT. A review of cerebral vasospasm in aneurysmal subarachnoid haemorrhage. Part I: incidence and effects. J Clin Neurosci 1994; 1: 19-26.
4. Piepgras DG, Whisnant JP, Khurana VG. Ruptured giant intracranial aneurysms. Part 2: A retrospective analysis of timing and outcome of surgical treatment. J Neurosurg 1997 (submitted).
5. Seifert V, Löffler B-M, Zimmerman M, Roux S, Stolke D. Endothelin concentrations in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 1995; 82: 55-62.
6. Weir B. The pathophysiology of cerebral vasospasm. Br J Neurosurg 1995; 9: 375-390.
7. Mayberg MR. The pathophysiology of arterial narrowing and delayed ischemic deficit after subarachnoid hemorrhage. In: Scriabine A, Teasdale GM, Tettenborn D, Young W (eds). Nimodipine-Pharmacological and Clinical Results in Cerebral Ischemia. Berlin: Springer-Verlag, 1991.
8. Dorsch NWC. A review of cerebral vasospasm in aneurysmal subarachnoid haemorrhage. Part II: management. J Clin Neurosci 1994; 1: 78-92.
9. Dorsch NWC. A review of cerebral vasospasm in aneurysmal subarachnoid haemorrhage. Part III: mechanisms of action of calcium antagonists. J Clin Neurosci 1994; 1: 151-160.
10. Dorsch NWC. Cerebral arterial spasm - a clinical review. Br J Neurosurg 1995; 9: 403-412.
11. Suzuki S, Takenaka K, Kassell NF, Lee KS. Hemoglobin augmentation of interleukin-1β-induced production of nitric oxide in smooth-muscle cells. J Neurosurg 1994; 81: 895-901.
12. Linnik MD, Lee TJ-F. Effect of hemoglobin on neurogenic responses and cholinergic parameters in porcine cerebral arteries. J Cereb Blood Flow Metab 1989; 9: 219-225.
13. G-nitro-L-arginine in isolated dog and monkey cerebral arteries. Stroke 1993; 24: 1584-1589.
14. Takenaka K, Kassell NF, Foley PL, Lee KS. Oxyhemoglobin-induced cytotoxicity and arachidonic acid release in cultured bovine endothelial cells. Stroke 1993; 24: 839-845.
15. Shepherd JT, Katusic ZS, Vedernikov Y, Vanhoutte PM. Mechanisms of coronary vasospasm: role of endothelium. J Mol Cell Cardiol 1991; 23 (Suppl I): 125-131.
16. Pearson PJ, Lin PJ, Schaff HV. Global myocardial ischemia and reperfusion impair endothelium-dependent relaxations to aggregating platelets in the canine coronary artery. J Thorac Cardiovasc Surg 1992; 103: 1147-1154.
17. Marshall JJ. Editorial comment. Stroke 1993; 24: 845-846.
18. Pearson PJ, Schaff HV, Vanhoutte PM. Acute impairment of endothelium- derived relaxations to aggregating platelets following reperfusion injury in canine coronary arteries. Circ Res 1990; 67: 385-393.
19. Juvela S. Aspirin and delayed cerebral ischemia after aneurysmal subarachnoid haemorrhage. J Neurosurg 1995; 82: 945-952.
20. Gold ME, Buga GM, Wood KS, Byrns RE, Chaudhuri G, Ignarro LJ. Antagonistic modulatory roles of magnesium and calcium on release of endothelium-derived relaxing factor and smooth muscle tone. Circ Res 1990; 66: 355-366.
21. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002-2012.
22. Änggård E. Nitric oxide: mediator, murderer, and medicine. Lancet 1994; 343: 1199-1206.
23. Altura BM, Altura BT. New perspectives on the role of magnesium in the pathophysiology of the cardiovascular system. Magnesium 1985; 4: 245-271.
24. Shine KI. Myocardial effects of magnesium. Am J Physiol 1979; 237: H413-H423.
25. Bliss TV, Collingridge GL. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993; 361: 31-39.
26. Sjögren A, Edvinsson L. The influence of magnesium on the release of calcium from intracellular depots in vascular smooth muscle cells. Pharmacol Toxicol 1988; 62: 17-21.
27. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-376.
28. Furchgott RF. The role of endothelium in the responses of vascular smooth muscle to drugs. Annu Rev Pharmacol Toxicol 1984; 24: 175-197.
29. Palmer RMJ, Ferridge AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-526.
30. Katusic ZS, Milde JH, Cosentino F, Mitrovic BS. Subarachnoid hemorrhage and endothelial L-arginine pathway in small brain stem arteries in dogs. Stroke 1993; 24: 392-399.
31. Lüscher TF. The endothelium and cardiovascular disease - a complex relation. N Engl J Med 1994; 330: 1081-1083.
32. Shepherd JT, Katusic ZS. Endothelium-derived vasoactive factors: I. Endothelium-dependent relaxation. Hypertension 1991; 18 (Suppl III): III76-III85.
33. Afshar JKB, Pluta RM, Boock RJ, Thompson BG, Oldfield EH. Effect of intracarotid nitric oxide on primate cerebral vasospasm after subarachnoid haemorrhage. J Neurosurg 1995; 83: 118-122.
34. Bredt DS, Hwang PM, Snyder SH. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 1990; 347: 768-770.
35. Kasuya H, Weir BK, Nakane M, Pollock JS, Johns L, Marton LS, Stefansson K. Nitric oxide synthase and guanylate cyclase levels in canine basilar artery after subarachnoid hemorrhage. J Neurosurg 1995; 82: 250-255.
36. Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, Snyder SH. Cloned and expressed nitric oxide synthase structurally resembles cytochrome p-450 reductase. Nature 1991; 351: 714-718.
37. Verma A, Hirsch D, Glatt CE, Ronnett GV, Snyder SH. Carbon monoxide: a putative neural messenger. Science 1993; 259: 381-384.
38. G-monomethyl-L- arginine in canine basilar artery. Stroke 1991; 22: 1399-1404.
39. Palmer RMJ, Moncada S. A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells. Biochem Biophys Res Comm 1989; 158: 348-352.
40. 2+-dependently converts L-arginine into an activator of soluble guanylyl cyclase. Biochem Biophys Res Comm 1989; 164: 678-685.
41. Rees DD, Palmer RMJ, Schulz R, Hodson HF, Moncada S. Characterisation of three inhibitors of nitric oxide synthase in vitro and in vivo. Br J Pharmacol 1990; 101: 746-752.
42. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109-142.
43. Marín J, Sánchez-Ferrer CF. Role of endothelium-formed nitric oxide on vascular responses. Gen Pharmacol 1990; 21: 575-587.
44. Katusic ZS. Endothelial L-arginine pathway and regional cerebral arterial reactivity to vasopressin. Am J Physiol 1992; 262: H1557-H1562.
45. Cosentino F, Sill JC, Katusic ZS. Endothelial L-arginine pathway and relaxations to vasopressin in canine basilar artery. Am J Physiol 1993; 264: H413-H418.
46. Oyama H, Suzuki Y, Satoh S, et al. Role of nitric oxide in the cerebral vasodilatory responses to vasopressin and oxytocin in dogs. J Cereb Blood Flow Metab 1993; 13: 285-290.
47. Cosentino F, Katusic ZS. Does endothelin-1 play a role in the pathogenesis of cerebral vasospasm? Stroke 1994; 25: 904-908.
48. A receptor mRNA expression in a canine subarachnoid hemorrhage model. J Neurosurg 1994; 81: 759-764.
49. A- receptor antagonist BQ-123 and phosphoramidon on cerebral vasospasm. J Cardiovasc Pharmacol 1993; 22 (Suppl 8): S332-S335.
50. Kajita Y, Suzuki Y, Oyama H, et al. Combined effect of L-arginine and superoxide dismutase on the spastic basilar artery after subarachnoid hemorrhage in dogs. J Neurosurg 1994; 80: 476-483.
51. Katusic ZS, Shepherd JT. Endothelium-derived vasoactive factors: II. Endothelium-dependent contraction. Hypertension 1991; 18 (Suppl III): III86-III92.
52. Katusic ZS, Schugel J, Cosentino F, Vanhoutte PM. Endothelium-dependent contractions to oxygen-derived free radicals in the canine basilar artery. Am J Physiol 1993; 264: H859-H864.
53. Clarke-Haley E Jr, Kassell NF, Alves WM, et al. Phase II of tirilizad in aneurysmal subarachnoid haemorrhage - a report of the Cooperative Aneurysm Study. J Neurosurg 1995; 82: 786-790.
54. Khurana G, Bennett MR. Nitric oxide and arachidonic acid modulation of calcium currents in postganglionic neurones of avian cultured ciliary ganglia. Br J Pharmacol 1993; 109: 480-485.
55. Khurana G, Bennett MR. Arachidonic acid modulation of calcium channels in autonomie ciliary ganglia. Proc Aust Physiol Pharmacol Soc 1992; 23: 178P.
56. Gerzer R, Brash AR, Hardman JG. Activation of soluble guanylate cyclase by arachidonic acid and 15-lipoxygenase products. Biochim Biophys Acta (Amsterdam) 1986; 886: 383-389.
57. Gray GA, Schott C, Julou-Schaeffer G, Fleming I, Parratt JR, Stockley JC. The effect of inhibitors of the L-argininenitric oxide pathway on endotoxin induced loss of vascular responsiveness in anaesthetised rats. Br J Pharmacol 1991; 103: 1210-1224.
58. + channel. Nature 1989; 337: 555-557.
59. Sundt TM Jr, Szurszewski J, Sharbrough FW. Physiological considerations important for the management of vasospasm. Surg Neurol 1977; 7: 259-267.
60. Nagatani K, Masciopinto JE, Letarte PB, Haworth RA, Duff TA. The effect of hemoglobin and its metabolites on energy metabolism in cultured cerebrovascular smooth muscle cells. J Neurosurg 1995; 82: 244-249.
61. Clapp LH, Gurney AM. Modulation of calcium movements by nitroprusside in isolated vascular smooth muscle cells. Pflügers Arch 1991; 418: 462-470.
62. Bennett MR, Kerr R, Khurana G. Adenosine modulation of calcium currents in postganglionic neurones of avian cultured ciliary ganglia. Br J Pharmacol 1992; 106: 25-32.
63. Hirst GDS, Silverberg GD, van Helden DF. The action potential and underlying ionic currents in proximal rat middle cerebral arterioles. J Physiol 1986; 371: 289-304.
64. Tanoi C, Suzuki Y, Shibuya M, Sugita K, Masuzawa K, Asano M. Mechanism of the enhanced vasoconstrictor responses to endothelin-1 in canine cerebral arteries. J Cereb Blood Flow Metab 1991; 11: 371-379.
65. Khurana G, Kerr R, Bennett MR. Modulation of calcium currents by adenosine and nitric oxide in the parasympathetic neurons of cultured avian ciliary ganglia. Proc Aust Neurosci Soc 1992; 3: 73.
66. Popovic EA, Danks RA, Siu KH. Experience with nimodipine in aneurysmal subarachnoid haemorrhage. Med J Aust 1993; 158: 91-94.
67. Schilling L, Parsons AA, Wahl M. Effects of potassium channel activators on isolated cerebral arteries of large and small diameter in the cat. J Neurosurg 1995; 83: 123-128.
68. Williams PL, Warwick R, Dyson M, Bannister LH (eds). Gray's Anatomy, 37th edn. Edinburgh: Churchill Livingstone, 1989.
69. Hill CE, Hirst GDS, Silverberg GD, van Helden DF. Sympathetic innervation and excitability of arterioles originating from the rat middle cerebral artery. J Physiol 1986; 371: 305-316.
70. Edwards DH, Byrne JV, Griffith TM. The effect of chronic subarachnoid hemorrhage on basal endothelium-derived relaxing factor activity in intrathecal cerebral arteries. J Neurosurg 1992; 76: 830-837.
71. Sutter B, Suzuki S, Kassell NF, Lee KS. Characteristics of relaxation induced by calcitonin gene-related peptide in contracted rabbit basilar artery. J Neurosurg 1995; 82: 91-96.
72. Toda N, Ayajiki K, Okamura T. Neural mechanism underlying basilar arterial constriction by intracisternal L-NNA in anesthetized dogs. AmJ Physiol 1993; 265: H103-H107.
73. Maynard KI, Ogilvy CS. Patterns of peptide-containing perivaseular nerves in the circle of Willis: their absence in intracranial arteriovenous malformations. J Neurosurg 1995; 82: 829-833.
74. Gonzalez C, Estrada C. Nitric oxide mediates the neurogenic vasodilation of bovine cerebral arteries. J Cereb Blood Flow Metab 1991; 11: 366-370.
75. G-nitro-arginine on the synthesis of EDRF and the cerebroarterial response to vasodilator nerve stimulation. Life Sci 1990; 47: 345-351.
76. Auch-Schwelk W, Katusic ZS, Vanhoutte PM. Nitric oxide inactivates endothelium-derived contracting factor in the rat aorta. Hypertension 1992; 19: 442-445.
77. Bult H, Boeckxstaens GE, Pelckmans PA, Jordaens FH, Van Maercke YM, Herman AG. Nitric oxide as an inhibitory non-adrenergic non-cholinergic neurotransmitter. Nature 1990; 345: 346-347.
78. Waldman SA, Murad F. Biochemical mechanisms underlying vascular smooth muscle relaxation: the guanylate cyclase-cyclic GMP system. J Cardiovasc Pharmacol 1988; 12 (Suppl 5): S115-S118.
79. Kim P, Schini VB, Sundt TM Jr, Vanhoutte PM. Reduced production of cGMP underlies the loss of endothelium-dependent relaxations in the canine basilar artery after subarachnoid haemorrhage. Circ Res 1992; 70: 248-256.
80. Sun Y, Rotenberg MO, Maines MD. Developmental expression of heme oxygenase isoenzymes in rat brain. Two HO-2 mRNAs are detected. J Biol Chem 1990; 265: 8212-8217.
81. Garthwaite J, Garthwaite G, Palmer RM, Moncada S. NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Eur J Pharmacol 1989; 172: 413.
82. Brune B, Ullrich V. Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase. Mol Pharmacol 1987; 32: 497.
83. Shafiq J, Suzuki S, Itoh T, Kuriyama H. Mechanisms of vasodilation induced by NKH477, a water-soluble forskolin derivative, in smooth muscle of the porcine coronary artery. Circ Res 1992; 71: 70-81.
84. Sako M, Nishihara J, Ohta S, Wang J, Sakaki S. Role of protein kinase C in the pathogenesis of cerebral vasospasm after subarachnoid hemorrhage. J Cereb Blood Flow Metab 1993; 13: 247-254.
85. Seto M, Sasaki Y, Sasaki T. Alteration in the myosin phosphorylation pattern of smooth muscle by phorbol ester. Am J Pathol 1990; 259: C769-C774.
86. Edvinsson L, Ekman R, Jansen I, McCulloch J, Mortensen A, Uddman R. Reduced levels of calcitonin gene-related peptide-like immunoreactivity in human brain vessels after subarachnoid hemorrhage. Neurosci Lett 1991; 121: 151-154.
87. Nozaki K, Uemura Y, Okamoto S, Kikuchi H, Mizuno N. Relaxant effect of calcitonin gene-related peptide on cerebral arterial spasm induced by experimental subarachnoid hemorrhage in dogs. J Neurosurg 1989; 71: 558-564.
88. Matsui T, Takuwa Y, Johshita H, Yamashita K, Asano T. Possible role of protein kinase C-dependent smooth muscle contraction in the pathogenesis of chronic cerebral vasospasm. J Cereb Blood Flow Metab 1991; 11: 143-149.
89. Nishizawa S, Nezu N, Uemura K, Direct evidence for a key role of protein kinase C in the development of vasospasm after subarachnoid hemorrhage. J Neurosurg 1992; 76: 635-639.
90. Crompton MR. The pathogenesis of cerebral infarction following the rupture of cerebral berry aneurysms. Brain 1964; 87: 491-510.
91. Weir B. Aneurysms Affecting the Nervous System. Baltimore: Williams & Wilkins, 1987.
92. Suzuki J, Ohara H. Clinicopathological study of cerebral aneurysms: origin, rupture, repair and growth. J Neurosurg 1978; 48: 505-514.
93. Fisher CM, Kistler JP, Davis TM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980; 6: 1-9.
94. Liszczak TM, Varsos VG, Black PM, Kistler JP, Zervas NT. Cerebral arterial constriction after experimental subarachnoid hemorrhage is associated with blood components within the arterial wall. J Neurosurg 1983; 53: 18-26.
95. Chamley-Campbell JH, Campbell GR, Ross R. Phenotype-dependent response of cultured aortic smooth muscle to serum mitogens. J Cell Biol 1981; 89: 378-383.
96. Burke JM, Ross R. Collagen synthesis by monkey cells during proliferation and quiescence in culture. Exp Cell Res 1977; 197: 387-395.
97. Fager G, Hansson GK, Gown AM, Larson DM, Skalli O, Bondjers G. Human arterial smooth muscle cells in culture: inverse relationship between proliferation and expression of contractile proteins. In Vitro Cell Dev Biol 1989; 25: 511-520.
98. Macdonald RL, Wallace MC, Montanera WJ, Glen JA. Pathological effects of angioplasty on vasospastic carotid arteries in a rabbit model. J Neurosurg 1995; 83: 111-117.
99. Kaoutzanis MC, Peterson JW, Anderson RR, McAuliffe DJ, Sibilia RF, Zervas NT. Basic mechanism of in vitro pulseddye laser-induced vasodilation. J Neurosurg 1995; 82: 256-261.
100. Zervas NT, Liszczak TM, Mayberg MR, Black PM. Cerebrospinal fluid may nourish cerebral vessels through pathways in the adventitia that may be analogous to systemic vasa vasorum. J Neurosurg 1982; 56: 475-481.
101. Bennett MR. Nitric oxide release and long term potentiation at synapses in autonomic ganglia. Gen Pharmac 1994; 25: 1541-1551.